Sickle Cell Disease Treatment Demonstration Program
The summary for the Sickle Cell Disease Treatment Demonstration Program grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Health Resources and Services Administration, which is the U.S. government agency offering this grant.
Sickle Cell Disease Treatment Demonstration Program: This notice announces the opportunity to apply for funding under the Sickle Cell Disease Treatment Demonstration Program (TDP). The purpose of the TDP is to increase access for individuals with sickle cell disease (SCD) to quality, coordinated, comprehensive care by: 1) increasing the number of clinicians or health professionals knowledgeable about the care of SCD, 2) improving the quality of care provided to individuals with SCD, and 3) improving care coordination with other providers.
| Federal Grant Title: | Sickle Cell Disease Treatment Demonstration Program |
| Federal Agency Name: | Health Resources and Services Administration (HHS-HRSA) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | HRSA-21-032 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.365 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | May 3rd, 2021 |
| Original Application Deadline: | May 3rd, 2021 |
| Posted Date: | February 23rd, 2021 |
| Creation Date: | February 23rd, 2021 |
| Archive Date: | July 2nd, 2021 |
| Total Program Funding: | $5,000,000 |
| Maximum Federal Grant Award: | $0 |
| Minimum Federal Grant Award: | $0 |
| Expected Number of Awards: | 5 |
| Cost Sharing or Matching: | No |
| Last Updated: | April 28th, 2021 |
- Category Explanation
- https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=8d24c351-2384-4209-a572-19c0af5fbe62
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Eligible applicants include a Federally-qualified health center, a nonprofit hospital or clinic, or a university health center that provides primary health care, that has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals who have sickle cell disease; and demonstrates to the HRSA Administrator that either the federally-qualified health center, the nonprofit hospital or clinic, the university health center, the organization or entity described in clause (i) 42 USC § 300b-5, or experts as described in paragraph (2)(C) of 42 USC § 300b-5, has at least five (5) years of experience in working with individuals who have sickle cell disease. Federally-qualified health center is defined in section 1905(l)(2)(B) of the Social Security Act (42 U.S.C. 1396d(l)(2)(B)).
- Grant Announcement Contact
- Department of Health and Human Services, Health Resources and Services Administration
[email protected]
Contact Alisha S. Keehn, MPA at (301)945-4817 or email [email protected] - Similar Government Grants
- • Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program
- • Sickle Cell Disease Treatment Demonstration Program Regional Collaborative
- • Sickle Cell Treatment Demonstration Program
- More Grants from the Health Resources and Services Administration
- • Center for Maternal and Child Health Medicaid Partnerships
- • Maternal and Child Health Policy Innovation Program
- • Rural Northern Border Region Outreach Program
- • Delta Health Systems Implementation Program
- • Fiscal Year 2024 Behavioral Health Service Expansion